Clinical Study of a New Treatment Model for Elderly Lung Cancer Patients
Recruiting · NCT07632664 · Interventional (participants receive a specific treatment) · Lead sponsor: Peking University People's Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Pulmonary Lobectomy plus Mediastinal Lymph Node SamplingPulmonary Segmentectomy plus Mediastinal Lymph Node SamplingPulmonary Wedge Resection plus Mediastinal Lymph Node Sampling
What this trial is about
This multicenter prospective clinical study focuses on elderly patients with lung cancer. The investigators will build a standardized clinical registry database, develop perioperative risk stratification and surgical early-warning models, optimize individualized surgical regimens, construct multidisciplinary perioperative comprehensive therapy, integrated Chinese-Western medicine full-cycle management and personalized postoperative rehabilitation systems, so as to form a whole-process optimized treatment model for elderly lung cancer.
Who can take part
Age range
65 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Aged ≥65 years old
- Pathologically confirmed non-small cell lung cancer with clinical stage eligible for curative surgical resection
- Complete preoperative geriatric comprehensive assessment data available
- Capable of finishing planned surgery and long-term follow-up
- Voluntarily sign informed consent form
Exclusion criteria
- History of other malignant tumors within recent 5 years
- Severe organic dysfunction of heart, liver, renal or respiratory system that cannot tolerate thoracic surgery
- Preoperative confirmed distant metastasis preventing radical resection
- Uncontrolled active severe infection or obvious coagulation disorders
- Severe psychiatric disorder or cognitive dysfunction failing to cooperate with treatment and follow-up
- Refuse random grouping and postoperative regular monitoring
Where it is running
1 location listed.
- Peking University People's Hospital - Beijing, Beijing Municipality, China